---
title: Recently Added Hazardous Drugs
description: A list of drugs that our customers have recently added to their hazardous drugs list in Rhazdrugs.
---

[![Rpharmy TM](https://www.rpharmy.com/hubfs/Rpharmy%20TM.svg)

](https://www.rpharmy.com/?hsLang=en-us)

## Recently Added Hazardous Drugs

Check back here to review drugs our customers have recently added to their Hazardous Drugs list.

[ Schedule a Demo ](https://demo.rpharmy.com/)

The FDA has recently approved these drugs, and some of our customers have added them to their hazardous drug lists. We're sharing this with you so you can add it to your hazardous drug list should you choose.

Check back here often and follow Rpharmy on [Twitter](https://twitter.com/rpharmy) for the latest. 

- **pertuzumab; trastuzumab; hyaluronidase - zzxf (Phesgo®)**
- **tafasitamab - cxix (Monjuvi®)**
- **isatuximab - irfc (Sarclisa®)**
- **trastuzumab; hyaluronidase - oysk (Herceptin Hylecta®)**
- **calaspargase pegol - mknl (Asparlas®)**
- **teplizumab (Tzield®)**
- **mirvetuximab soravtansine (Elahere®)**
- **mavacamten (Camzyos®)**
- **oteseconazole (Vivjoa®)**
- **ganaxolone (Ztalmy®)**
- **tirzepatide (Mounjaro®)**
- **tremelimumab (Imjudo®)**
- **futibatinib (Lytgobi®)**
- **teclistamab (Tecvayli®)**
- **pirtobrutinib (JAYPIRCA®)**
- **elacestrant (Orserdu®)**
- **mosunetuzumab (Lunsumio®)**
- **adagrasib (Krazati®)**
- **olutasidenib (Rezlidhia®)**
- **anacaulase-bcdb (Nexobrid®)**
- **elacestrant (Orserdu®)**
- **retifanlimab (Zynyz®)**
- **Lurbinectedin (Zepzelca®)**
- **Epcoritamab-bysp (Epkinly®)**
- **ritlecitinib (Litfulo®) **
- **niraparib-abiraterone(Akeega®)**
- **momelotinib (Ojjaara)**
- **elranatamab-bcmm (Elrexfio)**
- **talquetamab-tgvs (Talvey)**
- **repotrectinib (Augtyro)**
- **capivasertib (Truqap)**
- **fruquintinib (Fruzaqla)**
- **quizartinib (Vanflyta)**
- ****toripalimab-tpzi (Loqtorzi)****
- **mirikizumab (Omvoh)**
- **nirogacestat (Ogsiveo)**
- **eflornithine (Iwilfin™)**

## Rhazdrugs

- [Rhazdrugs](https://www.rpharmy.com/rhazdrugs?hsLang=en)
- [Rhazdrugs 2-Minute Introduction Video](https://www.rpharmy.com/rhazdrugs-2-minute-intro-video?hsLang=en-us)
- [Rhazdrugs FAQs](https://www.rpharmy.com/rhazdrugs-faqs?hsLang=en)
- [Hazardous Drugs Resources](https://www.rpharmy.com/hazardous-drugs-resources-page?hsLang=en-us)
- [Recently Added Hazardous Drugs](https://www.rpharmy.com/en-us/recently-added-hazardous-drugs?hsLang=en-us)
- [USP <800> Lunch + Learn Webinar Videos](https://www.rpharmy.com/usp-800-lunch-and-learn-videos?hsLang=en-us)
- [What is USP <800>?](https://www.rpharmy.com/rhazdrugs-3?hsLang=en-us)
- [NEW ROI Case Study for Rhazdrugs](https://www.rpharmy.com/roi_case_study?hsLang=en-us)

[![Request Demo](https://no-cache.hubspot.com/cta/default/6609875/493f23e5-7a24-4167-891f-a40d98f99a5c.png)](https://cta-redirect.hubspot.com/cta/redirect/6609875/493f23e5-7a24-4167-891f-a40d98f99a5c)

<https://www.rpharmy.com/?hsLang=en-us>

PO Box 340220  
Austin TX 78734

info@rpharmy.com[tel:+18004671907](tel:+18004671907)

<https://www.linkedin.com/company/rpharmy/> <https://x.com/rpharmy> <https://www.youtube.com/@rpharmy> <https://www.facebook.com/rpharmy>

[![texas historically underutilized business program certified](https://www.rpharmy.com/hs-fs/hubfs/texas%20historically%20underutilized%20business%20program%20certified.png?width=126&height=109&name=texas%20historically%20underutilized%20business%20program%20certified.png)](https://www.rpharmy.com/blog/womanownedbusiness?hsLang=en-us)

© 2026 Rpharmy. All Rights Reserved. [Privacy Policy](https://www.rpharmy.com/en-us/recently-added-hazardous-drugs#)